Peter Wolf
Dermatology — Medical University of Graz, Austria
Peter Wolf
LeadR Profile
Dermatology
Subspecialties: Immunology - Biochemistry - Oncology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1989 - 2026
Number : 366
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| A stromal β-defensin, DEFB124, contributes to cutaneous host defense against Staphylococcus aureus. cells, staphylococcus, phototherapy, defensins, fibroblasts, staphylococcus aureus, stromal cells, immunity, innate, infections, dermatitis, atopic | iScience | 2026 | 0 |
| When a haematoma is not a haematoma. neoplasms, biopsy, therapeutics | Skin Health Dis | 2026 | 0 |
| Effect and length of doxycycline administration in elderly patients with bullous pemphigoid. doxycycline, pharmaceutical preparations, skin diseases, pemphigoid, bullous, aged, therapeutics | J Dtsch Dermatol Ges | 2026 | 0 |
| Correction: Cell‑autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53‑driven senescence and confers an immune‑active tumor microenvironment. cells, neoplasms, prostate, genes, p53, prostatic neoplasms, tumor microenvironment | Mol Cancer Top journal | 2026 | 0 |
| The Effect of Water-Filtered Infrared-A (wIRA) Radiation on Morphea: An Intra-Individual Pilot Split-Study. skin, scleroderma, localized, pilots, fibrosis, skin diseases | Exp Dermatol | 2026 | 0 |
Clinical Studies 21
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
3 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Hidradenitis Suppurativa Evaluation of lutikizumab in Adult and Adolescent Subjects 2024-510730-40-00 — safety, hidradenitis suppurativa, signs and symptoms, hidradenitis, adolescent | Phase 3 | Active not recruiting | 2024 |
| A study to test whether spesolimab helps people with a skin condition called pyoderma gangrenosum 2024-514306-31-00 — skin, safety, multiple chronic conditions, therapeutics, pyoderma, pyoderma gangrenosum | Phase 3 | Recruiting | 2025 |
| Urinary Microbiome as a Biomarker for Melanoma Diagnosis and Response Prediction to Systemic Tumour Therapy NCT07635732 — pilot projects, pilots, melanoma, neoplasms, biomarkers, diagnosis, therapeutics, bacteria, gastrointestinal microbiome | N/A | Recruiting | 2025 |
LeadR Networks
Main global connection map